Post by
gojotv! on Feb 14, 2023 1:15pm
This is what I was waiting to hear
From the ASCO press release:
"The interim data support that treatment with Photo Dynamic Therapy provides a viable treatment option for patients with BCG unresponsive CIS (+/- papillary disease) with an acceptable ongoing safety profile. Clinical trial information: NCT03945162."
Comment by
gojotv! on Feb 14, 2023 1:18pm
Now that all these diverse experts agree that TLD-1433 is commercially viable, all we need is for the FDA to answer the next question: Are we gonna do this fast or slow? Come through, BTD! Then, AA, and to the moon! GLTA of us!
Comment by
Lesalpes29 on Feb 15, 2023 7:14am
For me it's already slow! Hope the pace will accelerate for shareholders but more importantly the patients that need more options. When is the next financial, end of February? GL
Comment by
Yajne on Feb 15, 2023 10:34am
As a 'venture' company, next financial report is May1 when they report Q4 and full year together.
Comment by
enriquesuave on Feb 15, 2023 11:05am
May1st is same date as AUA meeting. It might be epic if they show increasing efficacy from 28% 450 day CR rate. Just IMO
Comment by
Eoganacht on Feb 15, 2023 12:21pm
They usually release the annual financial statement at the end of April, so maybe we'll see an MD&A in the last week of April before the poster session on Monday, May 1. Then one month later we should see another MD&A with the 1st quarter 2023 financial statement.
Comment by
enriquesuave on Feb 15, 2023 12:29pm
Most probably, we should get Update of data in MD&A with latest data up to about mid Apri perhaps, AUA will probably be data until early February IMO. The trend will hopefully see increasing efficacy or at least a 28% CR maintained across. FDA BTD and path to AA may come around the same time?
Comment by
Yajne on Feb 15, 2023 12:42pm
I still hope Dr Kulkarni will speak to an updated dataset when he presents tomorrow at GU-ASCO, If so, there is still tomorrow AM to issue NR with this data before the meeting, Fingers crossed! I have trouble comprehending why he might limit his presentation to the older data, especially if newest data would somewhat mitigate/dilute the effects of the initial undertreated patients.
Comment by
ramrodretired on Feb 16, 2023 6:43am
What time is the good doc presenting?
Comment by
Lesalpes29 on Feb 16, 2023 6:58am
The GU-ASCO cancer symposium will take place between February 16th to 18th, 2023 in San Francisco, California with the poster presented for general viewing and discussion within Poster Session B: Prostate Cancer and Urothelial Carcinoma on February 17, 2023 at 12:30 PM to 2:00 PM and 5:15 PM to 6:15 PM.